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Background/aim: We evaluated the existing risk factors with clinical results in patients who underwent major and minor amputation
of the lower extremity as a result of diabetic foot ulcers (DFUs).
Materials and methods: We retrospectively studied 107 patients who had undergone lower extremity amputation. The patients were
divided into minor (Group 1, n = 75) and major (Group 2, n = 32) amputation groups. On clinical evaluation, the type of surgery
performed, smoking history, comorbidities, duration of diabetes mellitus (DM) diagnosis, duration of DFU presence, peripheral
neuropathy, peripheral arterial disease, results of deep tissue culture, length of hospitalization, and blood parameters were investigated.
Results: In Group 2, mean hospitalization time was significantly longer than in Group 1 (P < 0.05). The proportion of patients with
Wagner Grade 4 was significantly higher in Group 2 than in Group 1 (P < 0.05). The duration of DM and DFU was significantly longer
in Group 2 (P < 0.05). The number of polymicrobial agents was significantly higher in Group 1 (P < 0.05).
Conclusion: In our study, the most important risk factors that led to major amputation in patients with DFU were age, Wagner
classification, duration of DM, duration of DFU, and C-reactive protein level.
Key words: Diabetic foot, foot ulcer, amputation, infection, Wagner classification, surgery

1. Introduction
Diabetes mellitus (DM) is a major public health problem
and diabetic foot incidence increases with the prevalence
of DM (1–3). Diabetic foot ulcer (DFU) is one of the major
complications of DM and occurs at an estimated rate of
10%–25% in diabetic patients in their lifetime (1–5). In
addition, 40%–85% of nontraumatic amputations consist
of diabetic foot amputations (6,7).
DFU causes increased morbidity and decreased quality
of life, incurs high treatment costs, and leads to high rates
of lower extremity amputation (LEA) (3,4,8). Death rates
5 years after a major amputation can be as high as 78% (8).
The diabetic foot is a multifactorial disorder (2,4,5).
DM causes a range of complications such as nephropathy,
retinopathy, neuropathy, DFUs, and cardiovascular disease.
The incidence of complications is expected to increase
with the rising number of diabetic patients (1,3,6,9). In
particular, diabetic neuropathy and peripheral arterial
disease that causes angiopathy are two major risk factors
that play a role in the development of DFUs (1,3,6,9).
Regardless of DM, we can list smoking, comorbidities,
alcoholism, use of steroids or toxic drugs, congenital
* Correspondence: firatozan9@gmail.com

wound healing problems, malnutrition, and old age as
additional risk factors for foot ulcers (9).
Despite the well-defined risk factors in the
development of DFU, there are factors that predict major
or minor amputation related to the diabetic foot. Age, sex,
ulcer depth, severity of infection, ischemia, osteomyelitis,
duration of diabetes, neuropathy, and glycemic control are
considered as potential predictors of amputation in DFU
(6,10).
In this study, we tried to determine the risk factors
that may cause amputation type by comparing the existing
clinical results of patients with major or minor amputation
of a lower extremity due to diabetic foot. Our hypothesis is
that risk factors in diabetic foot are effective in determining
the level of amputation.
2. Materials and methods
We retrospectively studied 268 patients. After the first
evaluation, patients who were treated without amputation
or those with Grade 0, 1, 2, or 5 lesions according to the
Wagner classification were excluded. The remaining 107
patients (56 males, 51 females; 64 right side, 43 left side;
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mean age, 60.08 years; range, 43–88 years) who underwent
LEA due to DFU between March 2011 and November
2015 were evaluated. The patients were divided into minor
(Group 1, n = 75) and major (Group 2, n = 32) amputation
groups. A minor LEA was defined as any amputation
distal to the ankle joint, whereas a major LEA was any
amputation through or proximal to the ankle joint (11). The
general state of the patients and their extremities, such as
peripheral vascular status, neuropathy, and intraoperative
tissues, were considered as the criteria of the amputation
levels. Foot lesions of the patients were classified according
to the Wagner system: Grade 0- skin lesions absent,
hyperkeratosis below or above bony prominences; Grade
1- skin and immediate subcutaneous tissue are ulcerated;
Grade 2- lesions are deeper and may penetrate to tendon,
bone, or joint capsule; Grade 3- deep tissues are always
involved, osteomyelitis may be present; Grade 4- gangrene
of some portion of the toes or forefoot; Grade 5- the entire
foot is gangrenous (12).
The demographic data of the patients were recorded.
On clinical evaluation, the education level of the patient,
smoking history, history of foot trauma, comorbidities,
presence of improper foot care, duration of DM diagnosis,
duration of DFU presence, peripheral neuropathy, and
peripheral arterial disease (PAD) were investigated.
The peripheral vascular status was assessed by
palpation of the dorsalis pedis and posterior tibial pulses
on both feet. The presence of two or fewer of the four pedal
pulses indicated PAD. In addition, to determine peripheral
vascular history, the patients were asked whether they had
undergone any previous peripheral bypass surgery or
peripheral angioplasty (1,7).
Diabetic peripheral sensory neuropathy was defined
as the inability to perceive pressure with an amount
of 10 g using a nylon monofilament test (5). The test
was performed at three sites (two plantar, one dorsal)
of each foot while the patient’s eyes were closed (2,13).
The presence of associated comorbidities, including
renal diseases and cardiac/pulmonary/endocrinological
conditions, was examined.
Blood parameters were investigated, such as glycated
hemoglobin (HbA1c), preoperative leukocyte count
(WBC), sedimentation, C-reactive protein (CRP),
and serum albumin levels. Blood sugar was similarly
investigated, as to whether it was regulated or not. Blood
sugar regulation was assessed according to patients’ blood
sugar and HbA1c levels. In addition, we recorded the type
of surgical interventions performed, the results of deep
tissue culture received intraoperatively, and the length of
hospitalization.
2.1. Statistical analysis
Statistical analysis was performed using IBM SPSS
21.0 (IBM, Armonk, NY, USA). Frequency analysis
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was performed for categorical variables. The data were
expressed as numbers and percentages. Paired Student’s
t-tests and Pearson’s chi-square tests were used to compare
categorical data. P < 0.05 was considered as statistically
significant.
3. Results
Baseline characteristics are given in Table 1. Mean followup time was 23.7 months (range, 10–32). According to the
Wagner classification, Grades 3 and 4 disease was noted
in 36 (48%) and 39 (52%) patients, respectively, in Group
1 and 2 (6.2%) and 30 (93.8%) in Group 2 (χ2 = 0.018, P
= 0.046).
In this study, 18 (16.8%) patients had below-knee, 14
(13%) had Syme’s, 9 (8.4%) had metatarsal, 61 (57%) had
ray, and 5 (4.6%) had toe amputations (Table 2) (Figures
1a–1c). The mean length of hospitalization was 16.2 ±
7.35 days in Group 1 and 31.8 ± 13.6 days in Group 2 (P =
0.0001). There was no blood sugar regulation in 50 (66.6%)
and 22 (68%) patients, respectively (χ2 = 0.194, P = 0.66).
Regarding the preoperative blood parameters, the average
WBC count was 18.837 ± 2909.67/mm3 in Group 1 and
16.235 ± 6188.02/mm3 in Group 2 (P = 0.676), whereas
the mean sedimentation level was 56.3 ± 32.68 and 56.81
± 39.76 mm/h, respectively (P = 0.19). Mean CRP level
was 31.3 ± 14.61 and 37.1 ± 18.38 mg/dL, respectively (P
= 0.03), and mean serum albumin level was 3.6 ± 0.72 and
3.64 ± 0.82 g/dL, respectively (P = 0.239).
Mean diabetes duration was 8.49 ± 4.4 years in Group 1
and 9.5 ± 4.32 years in Group 2 (P = 0.045); mean HbA1c
was 10.27 ± 2.44% and 11.01 ± 2.71%, respectively (P =
0.675); and a low level of education was noted in 54.6%
and 65.6%, respectively (χ2 = 0.046, P = 0.830).
The mean duration of DFU was 4.24 ± 2.41 and
6.31 ± 2.49 months, respectively, in Groups 1 and 2 (P
= 0.001), whereas peripheral neuropathy was present
in 38 (50.6%) and 9 (28.1%), respectively (χ2 = 0.025, P
= 0.874). Peripheral vascular disease (PVD) was present
in 40 (53.3%) and 20 (62.5%), respectively (χ2 = 0.009,
P = 0.926). Although the power analysis was calculated,
the mean duration of DFU of both groups was used. The
statistical power of the study was calculated as 97.8%. A
smoking history was noted in 37 (49.3%) and 22 (68.7%)
patients, respectively (χ2 = 3.334, P = 0.068), whereas
26 (34.6%) and 15 (46.8%) patients, respectively, had a
Charcot foot deformity (χ2 = 1.663, P = 0.197).
The main direct cause was inadequate foot care in
39 patients (52%) in Group 1 and 17 (53.1%) in Group
2, followed by direct trauma in 9 (12%) and 17 (53.1%),
respectively (χ2 = 1.890, P = 0.169; χ2 = 1.103, P = 0.294).
There was no significant difference among the groups
in terms of the number of comorbidities (χ2 = 12.998, P
= 0.369). Six patients had no additional disease (4 in
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Table 1. Patient demographic characteristics and clinical outcomes.
Patient characteristics

Group 1
(n = 75)

Group 2
(n = 32)

P-value

Age (years), mean (range)

58.8 ± 8.74

62.8 ± 9.35

P = 0.002

Female
Male

40 (53.3)
35 (46.7)

11 (34.4)
21 (65.6)

χ2 = 1.332,
P = 0.248

Duration of diabetic foot ulcer (months)

4.24 ± 2.41

6.31 ± 2.49

P = 0.001

Duration of DM (years)

8.49 ± 4.40

9.5 ± 4.32

P = 0.045

HbA1c (%)

10.27 ± 2.44

11.01 ± 2.71

P = 0.675

WBC count

18,837 ± 2909.67

16,235 ± 6188.02

P = 0.676

Sedimentation

56.3 ± 32.68

56.8 ± 39.76

P = 0.19

CRP

31.3 ± 14.61

37.1 ± 18.38

P = 0.03

Albumin

3.60 ± 0.72

3.64 ± 0.82

P = 0.239

Mean length of hospitalization, days

16.2 ± 7.35

31.8 ± 13.6

P = 0.0001

36 (48)
39 (52)

2 (6.2)
30 (93.8)

χ2 = 0.018,
P = 0.046

4 (14.1)
33 (33.3)
34 (32.1)
4 (20.5)

2
12
13 (25)
5 (75)

χ2 = 12.998,
P = 0.369

50 (66.6)
22 (29.4)

22 (68.7)
10 (31.3)

χ2 = 0.194,
P = 0.66

36 (48)
39 (52)

15 (46.8)
17 (53.1)

χ2 = 1.890,
P = 0.169

37 (49.4)
38 (50.6)

23 (71.9)
9 (28.1)

χ2 = 0.025,
P = 0.874

35 (46.7)
40 (53.3)

12 (37.5)
20 (62.5)

χ2 = 0.009,
P = 0.926

38 (50.6)
37 (49.3)

10 (31.2)
22 (68.7)

χ2 = 3.334,
P = 0.068

49 (65.3)
26 (34.6)

17 (53.1)
15 (46.8)

χ2 = 1.663,
P = 0.197

Sex, n (%)

Wagner, n (%)
Grade 3
Grade 4
Number of comorbidities, n (%)
0
1
2
≥3
Blood sugar regulation, n (%)
Absent
Present
Inadequate foot care, n (%)
Absent
Present
Peripheral neuropathy, n (%)
Absent
Present
Peripheral arterial disease, n (%)
Absent
Present
Peripheral arterial disease, n (%)
Absent
Present
Charcot foot, n (%)
Absent
Present

DM: Diabetes mellitus; WBC: white blood cell; CRP: C-reactive protein.
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Table 2. Operation method.
Therapies

Number of cases

Minor amputation, n (%)
Metatarsal amputation
Ray amputation
Toe amputation

9 (8.4)
61 (57)
5 (4.6)

Major amputation, n (%)
Below-the-knee amputation
Syme’s amputation

Group 1, 2 in Group 2). Renal disease was identified in 15
patients (9 in Group 1, 6 in Group 2). Pulmonary disease
was detected in 52 patients (33 in Group 1, 19 in Group 2),
while 21 had endocrinological disease (16 in Group 1, 5 in
Group 2) and 77 had cardiac disease (54 patients in Group
1, 23 in Group 2; Table 3).
Deep tissue culture was negative in 4 (3.7%) patients
(3 in Group 1, 1 in Group 2). The most frequently isolated
pathogen was Staphylococcus aureus in both groups.
According to deep tissue culture results, polymicrobial
agents were found in 16 (21.3%) patients in Group 1 and
11 (34.3%) in Group 2 (χ2 = 5.453, P = 0.02; Table 4).
4. Discussion
We determined risk factors and clinical outcomes of major
and minor LEA in 107 patients treated for diabetic foot
disease. The main findings showed that age, duration of
DM, duration of DFU, CRP count, Wagner classification,
and length of hospitalization of major LEA were
significantly different compered to minor LEA.
DFU and amputations are acute health and
socioeconomic problems that negatively affect the quality
of life for diabetic patients and additionally create a high
economic burden for patients and society (3,5,14). DM is
the leading cause of amputations with an accounted rate of
40% of total amputations (15).
In our study, the proportion of patients with Wagner
Grade 4 was higher in the major LEA group than in the
minor LEA group. Sun et al. (16) showed that the risk of
amputation was strongly associated with high Wagner
grade classifications. Similarly, in other studies, Wagner
classification was reported to be a predictor of LEA
(6,10,17).
Low serum albumin and high HbA1c levels have been
reported to be risk factors for limb loss in cases of diabetic
foot (10,18). Serum albumin is used as a measure to evaluate
the nutritional status of the human body. Therefore, a low
serum albumin level implies poor nutrition, which causes
delayed wound healing (10). The mean HbA1c value is
used to indicate the level of diabetic control. HbA1c is a
risk factor for major amputation, which underlines the
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18 (16.8)
14 (13)

importance of controlling the underlying diabetes from
the point of view of functional prognosis, as well. Lehto
et al. (19) reported that plasma glucose levels and the risk
of amputation increase in a largely linear fashion. In our
study, we found no significant differences between the
major and minor amputation groups in terms of serum
albumin and HbA1c levels.
Baseline levels of acute phase reactants were associated
with increased amputation risk (6,20). In recent studies,
baseline CRP and sedimentation levels were reported to be
independent predictors of major amputations (6). Lipsky
et al. (20) showed that increased baseline levels of acute
phase reactants (WBC, CRP, and sedimentation) were
associated with clinical failure in diabetic foot infections
treated with broad-spectrum antibiotics. In our study, CRP
levels were significantly different in the major compared to
the minor amputation group.
Foot problems are common in diabetic patients over 40
years of age and are thought to increase with age (2,6,10).
Amputations associated with diabetic foot have been
reported to be more common in men than women. In our
study, the mean age of patients in the major amputation
group was significantly higher than that of the minor
amputation group. Most patients were male, concordant
with the literature. In contrast, decreasing age has been
reported to be an independent predictor of increased ulcer
risk (2). Although the reason for this finding is unclear,
it may be because older patients are probably less mobile
than younger patients and less exposed to potentially
traumatic situations for the foot at risk (2).
A relationship between the development of diabetic
foot and duration of DM has been reported (21). The
proportion of cases of diabetic foot leading to major
amputation significantly increases with increasing
duration of DM (18,21). In our study, the duration of DM
is at least 5 years in 91.5% of the patients with diabetic foot.
However, the duration of DM and DFU was significantly
higher in patients undergoing major amputation.
Clinical studies have reported that the measure of
peripheral neuropathy was the main predicting factor for
DFU (22). Other associations with DFU are PVD, limited
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Figure 1. a, b, c) Appearance before and after surgical interventions of Wagner’s Grade 4 disease in a diabetic foot patient.
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Table 3. Comparison of comorbidities.
Group 1
n (%)

Group 2
n (%)

P

Cardiac diseases

54 (72)

23 (71.8)

0.489

Pulmonary diseases

33 (44)

19 (59.3)

0.821

Endocrinological diseases

16 (21.3)

5 (6.6)

0.295

Renal diseases

9 (12)

6 (8)

0.451

Table 4. Isolated microorganisms and their characteristics.
Group 1 (n = 75)
n (%)

Group 2 (n = 32)
n (%)

MSSA

26 (34.8)

16 (50)

MRSA

10 (13.5)

4 (12.6)

Escherichia coli, ESBL+

2 (2.6)

1 (3.1)

Enterococcus faecalis, VRE+

2 (2.6)

2 (6.2)

Enterococcus faecalis, VRE–

2 (2.6)

1 (3.1)

Coagulase-negative staphylococci

4 (5.3)

4 (12.6)

Group B streptococci

10 (13.5)

2 (6.2)

Enterobacter cloacae

1 (1.3)

1 (3.1)

Pseudomonas aeruginosa

3 (4)

2 (6.2)

Acinetobacter baumannii

17 (22.7)

6 (18.8)

Staphylococcus saprophyticus

1 (1.3)

2 (6.2)

Hafnia alvei

1 (1.3)

-

Candida tropicalis

1 (1.3)

-

Proteus vulgaris/penneri

1 (1.3)

-

Klebsiella pneumoniae

2 (2.6)

2 (6.2)

Morganella morganii

1 (1.3)

-

Enterococcus casseliflavus/gallinarum

1 (1.3)

-

Burkholderia species

2 (2.6)

2 (6.2)

Ralstonia species

2 (2.6)

2 (6.2)

Proteus mirabilis

1 (1.3)

1 (3.1)

Citrobacter werkmanii

-

1 (3.1)

MSSA: Methicillin-sensitive Staphylococcus aureus; MRSA: methicillin-resistant
Staphylococcus aureus; ESBL: extended-spectrum β-lactamase; VRE: vancomycinresistant Enterococcus faecalis.
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joint mobility, foot deformities, and duration of DM with
limited relevance (2,23). Case-control and prospective
studies have confirmed that the 10-g monofilament test was
one of the strongest independent risk factors for foot ulcers
in diabetics (2,5,13,23). The most important risk factor for
peripheral neuropathy, diabetic foot syndrome, was 43.9%
in our study. Although the PVD rate was not significantly
different between the groups, 56% of all cases had PVD.
Furthermore, hemodialysis was an independent risk
factor of major limb amputation. Hemodialysis is the
final picture of renal microangiopathy and is a growing
problem for foot lesions in dialysis patients with diabetic
nephropathy. The frequency of amputation is about 10
times higher in patients on dialysis due to diabetes than in
those without dialysis (24).
Diabetic foot syndrome is a health problem with high
morbidity and mortality rates. Additionally, it creates an
economic burden due to lengthy hospital stays and hospital
costs (4,5,14). Mean hospital stay for diabetic patients
was reported to be two times longer than for nondiabetic
patients, and hospital costs for diabetic patients were three
times higher than for nondiabetic patients (14). In our
study, hospital stay was significantly longer in the major
amputation group.
Previous studies suggest that foot infection is a risk
factor in major amputation (25). In our study, all deep
tissue cultures were positive, except in 4 patients (3 in
Group 1, 1 in Group 2). Generally, in severe diabetic foot
infections there is more than one microorganism (26).
Pathogens are generally gram-positive bacteria; however,
very serious life-threatening infections with gram-

negative agents can be isolated (27). S. aureus, coagulasenegative Staphylococcus, and group B Streptococcus are the
most frequently isolated bacteria (26–28). In our patient
group, the four most frequently isolated bacterial agents
were methicillin-sensitive S. aureus (39.2%), Acinetobacter
baumannii (21.4%), methicillin-resistant S. aureus (13%),
and group B Streptococcus (12.2%), respectively. However,
the number of polymicrobial agents was significantly
higher in Group 1.
Empirical antibiotic treatment should be planned
according to the severity of diabetic foot infection and
possible etiologic agents. It may be sufficient to use
antibiotics, which are effective in aerobic gram-positive
roots in patients with no history of antibiotic use and
with mild–moderate infections. However, in patients
with advanced-stage diabetic foot infections, a broader
spectrum of antibiotics may be required when selecting
empirical antibiotics (26–28).
The present study was limited by its small patient
population. Another limitation of our study was its
retrospective character.
In conclusion, rigorous control of diabetes as
the primary disease is first required to avoid major
amputations from foot lesions and a marked reduction
in postoperative activity in daily life. For early treatment,
early detection of lesions and foot care are also important.
Diabetic foot is a disease with high morbidity. Although
the differences between minor and major diabetic foot
amputations are not marked by sharp boundaries, age,
Wagner classification, duration of DM, duration of DFU,
and CRP level may be risk factors for major amputation.
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